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1. Introduction 
Lung cancer is one of the most common cancers in the world (Chiang et al., 2010; Landis et 
al., 1998). Surgical removal of the tumor mass offers the best chance for a cure in patients 
with non-small-cell lung cancer. A tumor in stages I (confined to the lung without nodal or 
distant metastasis), II (involvement of only lymph nodes within the lung), and IIIA 
(involvement of nodes on the same side as the tumor) is considered potentially resectable 
for cure (Martini et al., 1995). 
Based on tumor size and location, lung surgery is mainly divided into three types: wedge 
resection (removal of a small area in one lobe of either right or left lung), lobectomy 
(removal of one lobe from a right or left lung), and pneumonectomy (removal of an entire 
right or left lung). The mortality rate is much higher after pneumonectomy (61%) than 
lobectomy (35%) (Gunluoglu et al., 2011). Among the post-surgical factors, aberrant local 
inflammation and abnormal fluid drainage are the most common for inducing pulmonary 
edema. Excessive accumulation of fluid in the alveoli causes lung injury and hinders 
functional recovery. A severe form of acute lung injury results in acute respiratory distress 
syndrome. Sudden and life-threatening lung failure is the most detrimental factor in post-
surgical mortality (Jordan et al., 2000).  
With the progression from lung injury to acute respiratory distress syndrome, 
proinflammatory cytokines are increased, such as interleukin-1ǃ (Donnelly et al., 1996; 
Geiser et al., 2001) and tumor necrosis factor-ǂ (Tremblay et al., 2002). However, the 
production of vascular endothelial growth factor is reduced in the early stage but not 
altered in the late stage (Medfor & Millar, 2006). Interleukin-1ǃ and tumor necrosis factor-
ǂ are further elevated in the sustained phase (Bhatia & Moochhala, 2004). The increases in 
proinflammatory cytokines are not correlated with injury-induced mortality (Donnelly et 
al., 1996). Corticosteroid which alters host inflammatory responses do not show beneficial 
effects in the early stage of acute respiratory distress syndrome (Kollef et al., 1995). 
Current reviews suggest that activation of inflammation-independent pathways in the 
early stage and inflammation-dependent pathways in the late stage contribute to the 
development of acute respiratory distress syndrome (Spragg et al., 2010; Bhatia & 
Moochhala, 2004).  
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To effectively reduce post-surgical mortality, early detection of acute respiratory distress 
syndrome may provide in-depth information for the design of management plans, including 
non-pharmacological therapies (Villar et al., 2011).  
2. Proteomic analysis of bronchoalveolar lavage fluid in biomarker studies 
To effectively identify the biomarkers of various lung diseases, bronchoalveolar lavage fluid 
from the lower airways and alveoli is collected for genomic or cytological analysis of cellular 
components (Meyer, 2007). This lung-specific fluid can be used for protein analysis. 
Identification of the non-cellular components in bronchoalveolar lavage fluid may provide 
valuable data for the early detection of acute lung injury.  
2.1 Current advances in proteomic analysis of bronchoalveolar lavage fluid 
In the past decades, over 100 human proteins or protein isoforms have been identified in 
bronchoalveolar lavage fluid from patients with various lung diseases (Wattiez et al., 
1999; Lenz et al., 1993; Sadaghdar et al., 1992; Sabounchi-Schütt et al., 2001; Vesterberg et 
al., 2001). The major challenge today is to identify the lead proteins and validate the 
potential biomarkers (Turtoi et al., 2011a). To overcome this difficulty, integration of 
clinical studies with proteomic analysis of bronchoalveolar fluid is a potential solution 
(Turtoi et al., 2011b).   
2.2 Sampling concern in proteomic analysis of bronchoalveolar lavage fluid 
In clinical proteomics, the most difficult challenge before sample analysis is patient selection 
and sample collection (Apweiler et al., 2009). In the case of lung cancer patients, the major 
concern is to collect bronchoalveolar lavage fluid from those who may develop post-surgical 
lung edema. Although both bronchoalveolar lavage fluid and bronchial washings are 
collected using similar procedures, the former is collected from terminal alveoli after 
instilling more than 140 ml of sterile saline and the latter is collected from major airways 
after instilling less than 140 ml of saline. Because of the concern that excessive fluid 
accumulation may cause the complication of lung edema, bronchial washing is a better 
choice for conducting clinical proteomics. 
2.3 Technical limitations in proteomic analysis of bronchoalveolar lavage fluid  
In conventional proteomic analysis, two-dimensional gel electrophoresis provides good 
protein separation. However, it restricts the discovery of proteins with extreme 
biochemical properties such as size, isoelectric point, and solubility (Rabilloud, 2002). In 
comparison, one-dimensional gel electrophoresis provides easy comparison of banding 
patterns in protein profiling but is less efficient in protein separation. Moreover, the high 
salt concentration in the bronchoalveolar lavage fluid interferes with the resolution of 
protein separation to a lesser extent in one-dimensional gel electrophoresis (Plymoth, 
2003).  
2.4 Application of 1D gel with liquid chromatography and MS/MS in biomarker 
discovery 
The rapid development of LC/MS/MS offers a better solution to one-dimensional gel 
electrophoresis (Schirle et al., 2003). A similar approach has been used to discover proteins 
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with molecular weight greater than 100 kDa (such as ǂ2-macroglobulin). The discovery of 
hundreds of proteins in bronchoalveolar lavage fluid demonstrates its feasibility in 
biomarker identification (Wu et al., 2005; Chang et al., 2007).  
2.5 Sensitivity and specificity of the lead proteins after proteomic analysis 
To accelerate the translation of biomarker discovery from bench to bedside, the 
development of techniques has been divided into 5 stages (Pepe et al., 2001). In Phase 1, 
potential biomarkers are discovered by various approaches, such as proteomic analysis. 
After the leads are identified by biochemical studies, measurable classifiers or outcomes are 
developed in Phase 2. Based on the analysis of their specificity and sensitivity, the cutoff 
point of the measurable outcome is determined and used in Phase 3. Based on patient 
history and clinical data, the number and nature of clinical cases is well defined in Phase 3. 
Suitable criteria for a clinical trial are determined in Phase 4. Phase 5 is a randomized trial to 
compare the specificity and sensitivity of the leads with those of current biomarkers in the 
market. 
Today, the importance of sensitivity and specificity in biomarker selection has shifted 
proteomic studies from large-scale analysis to clinically-relevant validation. In addition to 
large-scale analysis in protein or metabolite identification (Mou et al., 2011; Huang et al., 
2011), the leads are selected based on their sensitivity and specificity.  
3. Translational study from protein identification to clinical application 
The purpose of this study was to discover potential biomarkers for the early detection of 
acute respiratory distress syndrome. To avoid sampling-induced complications, bronchial 
washings from lung cancer patients before and after surgical therapy (lobectomy) were 
collected. To reduce population heterogeneity, cancer stage, hormonal variation, and tumor 
location were well-defined. Only patients older than 60 years, had right lung cancer at 
stages IA and IB, and agreed to receive right lung lobectomy were recruited.  
Those patients who met the inclusion and exclusion criteria were selected as controls. The 
inclusion criteria were: defined cancer in any lobe of the right lung, non-smoker, age ≥60 
years, elective operation, operation period <210 min, forced expiratory volume in 1 s (FEV1) 
>80%, and no prior major lung resection or thoracic irradiation. Exclusion criteria were: age 
<60 years, operation period >210 min, FEV1 <60%, emergency or urgent operation, and 
prior major lung resection or distant thoracic irradiation. Based on our criteria, 7 patients (5 
females and 2 males with ages ranging between 61 and 77 years) were included as controls. 
A review was conducted from the medical records and prospective database. The study 
protocol was approved by the Human Medical Studies Committee at National Cheng Kung 
University Medical College Hospital. Informed consent was given by all participants or their 
legal guardians .  
Prior to a large-scale analysis of proteins in bronchial washings, the protein profiles of 
washings from different compartments of the lungs before and after lobectomy were 
compared. In the right lung where tumor tissues were identified, no clear bands at 
molecular weights >75 kDa were found in washings collected before or after lobectomy. In 
the left lung, no clear bands at molecular weights >75 kDa were found in the washings 
collected before lobectomy. After lobectomy, more bands at molecular weights >75 kDa 
were found. The intensity of each band was much greater (Fig. 1). Similar patterns were 
found in all samples studied.  
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Fig. 1. Protein profiling of bronchial washes from right (RL) and left lungs (LL) from 
patients before (Pre-Op) and after (Post-Op) right lung lobectomy. Bovine serum albumin 
(BSA) was used a positive control because albumin was identified in various bands. 
The banding pattern allowed us to hypothesize that the proteins at molecular weights >75 
kDa are exuded into alveoli after surgery. One-dimensional gel electrophoresis coupled with 
LC/MS/MS allowed us to identify the proteins in 13 major bands. As listed in Table 1, 8 
proteins had molecular weights >100 kDa, including ǂ2-macroglobulin.  
To test our hypothesis that protein exudation is surgery-dependent, the relative abundance 
of ǂ1-antitrypsin (47 kDa) and ǂ2-macroglobulin (162 kDa) in bronchial washings was 
measured by Western blot analysis. ǂ1-antitrypsin was found in washings collected before 
and after lobectomy (data not shown) but ǂ2-macroglobulin was only found after lobectomy 
(Fig. 2).  
 
 
Fig. 2. Relative abundance of ǂ2-macroglobulin in bronchial washings before (Pre) and after 
(Post) lobectomy. 
α2-macroglobulin→ 
α2-macroglobulin→ 
α2-macroglobulin→ 
Patient 3 Patient 4 Patient 5 
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No GI 
number 
Protein name MW 
(kDa) 
No. of 
matched 
peptides 
Sequence 
coverage 
Score 
1 28780 apo-B100 precursor  516.384 6 2% 285 
2 1174412 spectrin ǂ chain, erythrocyte  280.904 5 3% 257 
3 134798 spectrin ǃ chain, erythrocyte  247.040 7 4% 291 
4 179674 complement component C4A 194.365 5 4% 216 
5 4557385 complement component 3 precursor 188.612 8 7% 451 
6 224053 ǂ2-macroglobulin  162.096 2 1% 86 
7 4557485 ceruloplasmin (ferroxidase) 122.998 2 2% 91 
8 1483187 inter-ǂ-trypsin inhibitor family 
heavy chain-related protein (IHRP) 
103.553 2 2% 82 
9 4507021 solute carrier family 4, anion 
exchanger, member 1 
102.017 3 4% 213 
10 6005942 valosin-containing protein  89.962 4 9% 130 
11 28592 serum albumin  71.351 12 19% 615 
12 3287489 hsp89-ǂ-δ-N 63.850 2 5% 85 
13 4504489 histidine-rich glycoprotein 
precursor 
60.527 2 4% 69 
14 553788 transferrin 55.233 4 10% 177 
15 69990 ǂ1-glycoprotein 52.488 2 6% 84 
16 386789 hemopexin precursor 52.266 2 2% 81 
17 38408 immunoglobulin M heavy chain 50.135 3 9% 112 
18 229601 Ig G1 H Nie 49.812 3 12% 127 
19 177827 ǂ1-antitrypsin 46.790 2 7% 67 
20 10334547 immunoglobulin heavy chain 42.319 2 8% 57 
21 123510 haptoglobin-related protein 
precursor 
39.505 2 6% 114 
22 121039 Ig gamma-1 chain C region 36.605 3 14% 118 
23 121043 Ig gamma-2 chain C region 36.500 2 11% 55 
24 183817 ǃ-globin 19.209 4 33% 221 
25 442753 Chain D, Hemoglobin Ypsilanti 16.021 5 50% 206 
Table 1. Proteins identified in bronchial washings from the left lung of a patient receiving 
right lung lobectomy. 
3.1 Vascular endothelial growth factor and lobectomy-induced inflammation 
Since vascular endothelial growth factor is a potent inducer of vascular permeability (Lee, 
2005) and its expression is positively correlated with inflammation-induced protein 
exudation and leukocyte infiltration (Chang et al., 2005), it is plausible to suggest that an 
increase in vascular endothelial growth factor is associated with surgery-induced protein 
exudation and leukocyte infiltration.  
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As shown in Table 2, the vascular endothelial growth factor level was positively correlated 
with total protein concentration (y = 0.0025x + 1.0755, R2 = 0.7359, P <0.05) and cell count  
(y = 0.0696x - 0.6441, R2 = 0.8463, P <0.05) but not with operation duration or PaO2/FiO2. The 
correlation analysis supported the hypothesis that the induction of vascular endothelial 
growth factor after surgery contributes to leukocyte infiltration and protein exudation. 
 
Patient 
No 
Operation 
duration (min) 
PaO2/FiO2 
 
Cell count 
(104 cells/ml) 
Protein conc. 
(μg/ml) 
VEGF 
(pg/ml) 
1 152 270.167 2.5 0.641 162.80 
2 191 202.500 67.0 3.412 613.68 
3 234 435.000 100.0 4.826 1517.40 
4 160 220.800 22.5 1.737 89.95 
5 196 336.000 3.5 2.462 99.79 
6 140 338.333 0.5 0.660 109.64 
7 221 505.600 5.0 1.302 359.69 
PaO2: arterial partial pressure of oxygen; FiO2: inspired oxygen fraction; PaO2/FiO2: oxygenation index 
Table 2. Clinical data of 7 patients who received right lung lobectomy without complications  
3.2 α2-macroglobulin and α1- antitrypsin in lobectomy-induced inflammation 
The relative expression of ǂ2-macroglobulin at bands 2, 4, and 5 from bronchial washings 
was correlated with protein concentration, leukocyte number, and the level of vascular 
endothelial growth factor (Fig. 3).  
 
 
 
Fig. 3. Correlation analysis of ǂ2-macroglobulin and VEGF/total cells in bronchial washings. 
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Likewise, the relative expression of ǂ1-antitrypsin at bands 5, 7, and 8 from bronchial 
washing was positively correlated with protein concentration, leukocyte number, and the 
level of vascular endothelial growth factor (data not shown). These data supported our 
hypothesis that the increase of vascular endothelial growth factor after surgery facilitates 
leukocyte infiltration and the exudation of acute-phase proteins (such as ǂ1-antitrypsin and 
ǂ2-macroglobulin) into alveoli.  
3.3 Characterization of α2-macroglobulin and α1-antitrypsin in lobectomized patients 
with acute respiratory distress syndrome  
Based on the report of the joint American–European Consensus Conference, the acute 
respiratory distress syndrome is well defined as follows: bilateral infiltrates on frontal chest 
radiography, the absence of left atrial hypertension (pulmonary capillary wedge pressure 
<18 mmHg or no clinical signs of left ventricular failure), and severe hypoxemia with a 
PaO2/FiO2 ratio <200 mmHg (Bernard et al., 1994). Five patients who received lung surgery 
and met these criteria were studied.  
3.3.1 Characterization of patients with acute respiratory distress syndrome 
The group with lobectomy free of complications had levels of total protein and total 
leukocyte numbers in their bronchial washings similar to those who developed acute 
respiratory distress syndrome (P >0.05, Fig. 4). These data indicate that lung surgery induces 
inflammation (leukocyte infiltration and protein exudation) in the groups with and without 
the complication of acute respiratory distress syndrome. So, factors other than inflammation 
contribute to the development of this syndrome. 
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Fig. 4. Total leukocyte number and protein concentration in patients before (pre-op) and 
after lobectomy (post-op) with no complication and those with acute respiratory distress 
syndrome (ARDS).  
In lung cancer patients, an increase of vascular endothelial growth factor is positively 
associated with poor prognosis (P = 0.018; Han et al., 2001) but not with a worse 
postoperative year-survival rate (P = 0.0643; Liao et al., 2001). These reports are also 
consistent with our finding that the increase of vascular endothelial growth factor after lung 
surgery does not contribute to surgery-induced acute respiratory distress syndrome. 
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3.3.2 Protein profiling of bronchial washings from lobectomized patients with acute 
respiratory distress syndrome 
Unlike patients with no complications, those with acute respiratory distress syndrome 
showed white or gray patches on the chest X-ray. In one-dimensional gel electrophoresis, 
the protein profiling of bronchial washings from patients without complications showed a 
much clearer banding pattern than those from patients with acute respiratory distress 
syndrome (Fig. 5). Eight bands from each gel were cut and subjected to LC/MS/MS for 
protein identification. No protein was identified in Lane 1. The most significant difference 
was that albumin appeared in almost every band of the samples from patients without 
complications but not in those with acute respiratory distress syndrome. In contrast, ǂ1-
antitrypsin was identified only in bands 6 and 7 from the group without complications but 
was found in bands 2, 3, 4, 5, 6, and 7 in the group with the complication (Fig. 5).  
 
 
 
Fig. 5. Comparison of chest X-rays and protein profiling of bronchial washings in 
lobectomized patients with no complications (lobectomy, Lob) and those with acute 
respiratory distress syndrome (ARDS).  
3.3.3 α2-macroglobulin and α1-antitrypsin in bronchial washings from lobectomized 
patients with acute respiratory distress syndrome 
As shown in Fig. 6, both ǂ2-macroglobulin and ǂ1-antitrypsin were detected in bronchial 
washings after surgery.  
After quantification, the total amounts of ǂ2-macroglobulin at bands 2, 4, and 5 and ǂ1-
antitrypsin at bands 5, 7, and 8 did not show any statistical difference between the groups 
with and without complications. The most important finding was lower levels of ǂ1-
antytrypsin at bands 7 and 8 in the group without complications than the acute respiratory 
distress syndrome group (Fig. 6). It is likely that ǂ1-antitrypsin variants at bands 5, 7, and 8 
can be used as biomarkers for the early detection of acute respiratory distress syndrome. 
In bronchial washings collected from the patients with acute respiratory distress syndrome, 
leukocyte number was not correlated with the total amounts of ǂ2-macroglobulin or ǂ1-
antitrypsin. Our analyses again supported the notion that surgery-induced inflammation is 
not an important indicator in the early phase of acute respiratory distress syndrome. 
It has been reported that ǂ1-antitrypsin can be produced by lung epithelial cells (Venember 
et al., 1994) but ǂ2-macroglobulin cannot. Our preliminary data confirmed the expression of  
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Fig. 6. Relative expression of ǂ1-antitrypsin and ǂ2-macroglobulin (macroglobulin) in the 
lobectomized group without complications (lobectomy) and in the group with acute 
respiratory distress syndrome (ARDS). 
ǂ1-antitrypsin in A549, a lung epithelial cell line. The changes in ǂ1-antitrypsin variants 
could be due to functional changes in lung epithelial cells. 
3.4 Specificity and sensitivity of α1-antitrypsin variants as potential biomarkers for 
acute respiratory distress syndrome 
It is of importance to turn the relative expression of ǂ1-antitrypsin in bronchial washings 
into a measurable outcome because only the measurable outcome is used to determine the 
cutoff value. Based on the cutoff value, sensitivity (the proportion of subjects who test 
positive among those with the condition) and specificity (the proportion of subjects who test 
negative among those without the condition) can be calculated.  
As shown in Fig. 6, ǂ1-antitrypsin variants at bands 7 (47 kDa) and 8 (40 kDa) had a lower 
abundance in the group without complications than the group with acute respiratory 
syndrome. To avoid variations in sample loading and the intensity in each calculation, the 
ratio of the expression of ǂ1-antitrypsin at band 5 (70 kDa) to that at bands 7 and 8 was used 
as the measurable outcome. Based on this calculation, the cutoff value was 0.5. A ratio <0.5 
was considered an indication of acute respiratory distress syndrome.  
Table 3 shows the ratio for each patient from the complication-free group. Four out of 7 
patients had a ratio <0.5. The specificity of ǂ1-antitrypsin for true negative patients was 0.43 
(3/7).  
Table 4 shows the ratio for each patient from the complication group. Three out of 5 patients 
had a ratio <0.5. The sensitivity of ǂ1-antitrypsin for true positive patients was 0.6 (3/5). 
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Patient 
No 
Ratio of expression of ǂ1-antitrypsin at band  
5 to that at bands 7 and 8 
Cutoff value = 0.5 
1 0.000: 0.027 <0.5 
2 0.043: 0.099 <0.5 
3 0.019: 0.024 >0.5 
4 0.017: 0.023 >0.5 
5 0.018: 0.087 <0.5 
6 0.000: 0.006 <0.5 
7 0.042: 0.053 >0.5 
 
Table 3. Ratio of the expression of ǂ1-antitrypsin at band 5 to that at bands 7 and 8 in the 
lobectomized patients without acute respiratory distress syndrome.  
 
Patient No Ratio of expression of ǂ1-antitrypsin at band  
5 to that at bands 7 and 8 
Cutoff value = 0.5 
A 0.081: 0.177 <0.5 
B 0.043: 0.199 <0.5 
C 0.081: 0.086 >0.5 
D 0.015: 0.040 <0.5 
E 0.025: 0.048 >0.5 
 
Table 4. Ratio of the expression of ǂ1-antitrypsin at band 5 to that at bands 7 and 8 in 
lobectomized patients with acute respiratory distress syndrome.  
3.5 Further improvement of specificity and sensitivity for detecting acute respiratory 
distress syndrome using dual biomarkers 
As shown in Tables 3 and 4, the sensitivity of ǂ1-antitrypsin variants for detecting acute 
respiratory distress syndrome (0.6) was better than the specificity (0.43). The major concern 
is how to optimize the cutoff value and improve the specificity. In table 3, patients 1 and 6 
with ratios <0.5 showed the lowest values in cell counts and protein concentration. 
Meanwhile, the expression of ǂ2-macroglobulin was almost undetectable, which indicates 
minor inflammation in the patients. The lower ratio of relative expression of ǂ1-antitrypsin 
at band 5 to that at bands 7 and 8 was false-positive. 
ǂ1-antitrypsin was found in the lungs before and after surgery; ǂ2-macroglobulin only 
occurred in the lungs after surgery. To avoid the lower levels of ǂ1-antitrypsin variants 
which may create a false-positive result, ǂ2-macroglobulin can be recruited as a second 
biomarker. The ratio of ǂ1-antitrypsin variants was considered as a true result only when 
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the sample expressed detectable ǂ2-macroglobulin in bronchial washings. Accordingly, the 
specificity for true negative patients changed to 0.71 (5/7). The prediction for true negatives 
was improved.  
4. From identification of leads to further validation using α2-macroglobulin 
and α1-antitrypsin variants as an example 
After the discovery of potential biomarkers by proteomic analysis in this study, the first 
challenge was to identify the leads from the proteins discovered after developing a quick 
screening test. After Phase 1, the second challenge was to provide clear justification to 
optimize the cutoff values.  
4.1 Contribution of this study to the discovery of biomarkers for detecting acute 
respiratory distress syndrome 
Ideally, quantitative proteomic analysis should be used to reveal lobectomy-induced 
changes of all proteins in bronchial washings. However, the unique compartment of the 
lung allowed us to analyze exudate components which may not exist before surgery, such as 
ǂ2-macroglobulin. Based on the important mechanism of surgery-induced inflammation in 
the early phase of lung injury, one-dimensional gel electrophoresis in this study was an easy 
and suitable tool to identify ǂ2-macroglobulin as an indicator of vascular endothelial growth 
factor-mediated permeability.  
The second contribution of this study was to take advantage of one-dimensional gel 
electrophoresis with pattern analysis to reveal the pattern changes of ǂ1-antitrypsin between 
the groups with and without post-surgical complications. The difference found allowed us 
to identify ǂ1-antytripsin variants as biomarkers for the early detection of acute respiratory 
distress syndrome.  
4.2 Limitations of this study 
In this study, ǂ1-antitrypsin variants were considered as biomarkers for acute respiratory 
distress. No mechanistic data are provided to explain why and how the formation of ǂ1- 
antitrypsin variants are related to the progression from surgery-induced inflammation to 
acute respiratory distress syndrome.  
The association between ǂ1-antitrypsin variants and infection was first reported in 2010 
(Zhang et al., 2010). The decrease of the ǂ1-antitrypsin variant at 130 kDa and the increase of 
the variant at 40 kDa is associated with human immunodeficiency virus-induced infection. 
Glycoproteomic analysis shows that changes in ǂ1-antitrypsin variants may be due to a shift 
of glycosylation. In future, glycoproteomic analysis of ǂ1-antitrypsin variants should be 
further explored.  
Although the analysis of their specificity and sensitivity, the cutoff point of the measurable 
outcome, and criteria for patient selection are clearly and easily determined, the small 
number of clinical cases in this study limits the generalization of ǂ2-macroglobulin and ǂ1-
antitrypsin as markers for acute respiratory distress syndrome. To use them as measurable 
biomarkers in Phase 3, it is necessary to increase the number and the complexity of clinical 
cases for further validation on whether the cutoff points determined are suitable for early 
diagnosis of acute respiratory distress syndrome.  
One-dimensional gel electrophoresis does not offer a good way for protein separation. 
Comparative proteomic analysis only compares the intensity of each spot. These two 
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approaches may our discovery of new proteins. The technology of stable isotope dimethyl 
labeling coupled with LC/MS/MS permits further quantification of specific peptides of each 
protein and provides a better quantification tool after one-dimensional electrophoresis (Huang 
et al., 2006). This approach then compensates for the limitation of one-dimensional gel 
electrophoresis. 
5. Conclusion 
Both inflammation -dependent and -independent mechanisms contribute to the progression 
from lung injury to acute respiratory distress syndrome. Stage-dependent changes in 
biomarkers allow us to monitor the progression of the diseases and develop new treatments 
in a stage-dependent manner.  
In this study, ǂ2-macroglobulin and ǂ1-antitrypsin were positively correlated with vascular 
endothelial growth factor, clearly showing lobectomy-induced inflammation. The total 
amount of ǂ1-macroglobulin can be used as a biomarker of increased vascular permeability 
in the lung. The severity of lobectomy-induced inflammation is similar to that of 
inflammation in acute respiratory distress syndrome but respiratory function becomes much 
worse in patients with the syndrome. Concomitantly, the patients with acute respiratory 
distress syndrome had lower levels of ǂ1-antitrypsin at higher molecular weights and 
higher levels of ǂ1-antitrypsin at lower molecular weights. Similarly, human 
immunodeficiency virus-induced infection is associated with the decreased abundance of 
ǂ1-antitrypsin at higher molecular weights and the increased abundance of ǂ1-antitrypsin at 
lower molecular weights (Zhang et al., 2010). Because ǂ1-antitrypsin exists in lung epithelial 
cells (Venember et al., 1994), the changes of ǂ1-antitrypsin variants in the patients with acute 
respiratory distress may reflect lung epithelial damage.  
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